This inventor holds 2 USPTO granted patents and 6 published patent applications and 5 EPO patents. Top assignees: Evonik Roehm Gmbh, Roehm Gmbh & Co Kg. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: The Innovative Journey of Michael Schnabel
Introduction
Michael Schnabel is a talented inventor based in Biebesheim, Germany, known for his notable contributions to the pharmaceutical industry. With two patents to his name, he has made significant strides in the development of innovative dosage forms and production methods.
Latest Patents
Schnabel's latest patents include a groundbreaking invention related to pharmaceutical dosage forms and methods for their production. This invention details a process for creating tablets, pellets, and active ingredient-containing matrices that integrate pharmaceutical active ingredients with a specific copolymer used as a coating and binding agent. The copolymer comprises 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate, and may contain up to 40 wt. % ethylacrylate, with a critical constraint that its glass transition temperature does not exceed 60°C, as per ISO standards. Another important patent revolves around a dispersion that serves as a coating agent and binder for pharmaceutical forms, made up of a solids content ranging from 10–70% by weight, showcasing his inventive prowess in pharmaceutical formulations.
Career Highlights
Michael Schnabel has had a commendable career, working with esteemed organizations such as Evonik Röhm GmbH and Röhm GmbH & Co. KG. His tenure at these companies has allowed him to leverage his expertise in pharmaceutical sciences, contributing to innovative research and development initiatives that enhance drug delivery systems.
Collaborations
Throughout his career, Schnabel has collaborated with several skilled professionals, including Hans-Ulrich Petereit and Thomas Suefke. These collaborations have played a critical role in advancing his inventions and patents, highlighting the importance of teamwork in the field of innovation.
Conclusion
Michael Schnabel's work exemplifies the spirit of innovation in the pharmaceutical industry. With his patented methods and formulations, he continues to push the boundaries of what is possible, paving the way for advancements that can significantly benefit healthcare solutions. Through dedication and collaboration, Schnabel remains a noteworthy figure among inventors in the realm of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile